Harshal Nandurkar

Evaluation of targeted immunotherapeutic agents in reducing haemophilia arthropathy in a murine model of haemophilia.

Nandurkar, H., Tran, H. & Hauw, W. S. W.

Haemophilia Foundation Australia

3/04/17 → 2/04/18

Project: Research

Delivering CD39 to the inured brain as a novel way to improve outcome after ischemic stroke

Nandurkar, H., Sashindranath, M., Sturgeon, S., Nesbitt, W. & Willcox, A.

1/02/17 → 31/01/18

Project: Research

Development of a novel drug to treat liver veno-occlusive disease: characterisation and pre-clinical testing

Nandurkar, H., Sashindranath, M., Sturgeon, S. & Willcox, A.

9/01/17 → 1/03/18

Project: Research

Fluorescence and internal reflection system to develop lab-on-chip devices

Nandurkar, H., Medcalf, R., Nesbitt, W., Rosengarten, G., Tovar-Lopez, F. & Peter, K.

Australian Research Council (ARC), Monash University, RMIT University, Baker Heart and Diabetes Institute

1/01/16 → 29/09/16

Project: Research

VCAM-targeted delivery of recombinant CD39 to the endothelium is antithrombotic, antiinflammatory and ameliorates ischaemia reperfusion injury

Nandurkar, H.

National Health & Medical Research Council (NHMRC)

1/01/15 → 31/12/18

Project: Research

The Characterisation of a 108 Kda Inositol Polyphosphate 5-phosphatase: Regulator of Cell Death

Mitchell, C. & Nandurkar, H.

Cancer Council Victoria

1/01/01 → 31/12/03

Project: Research

Regulation of Cell Growth and Differentiation by a Novel Phosphoinositide 3-phosphatase

Nandurkar, H. & Mitchell, C.

Australian Research Council (ARC)

1/01/00 → 31/12/00

Project: Research